PWG
TMO icon

Portside Wealth Group’s Thermo Fisher Scientific TMO Stock Holding History

Portside Wealth Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
2,282
+9
+0.4% +$4.32K 0.13% 166
2026
Q1 		$1.12M Buy
2,273
+103
+5% +$55.9K 0.15% 155
2025
Q4 		$1.26M Buy
2,170
+168
+8% +$95K 0.17% 139
2025
Q3 		$971K Sell
2,002
-8,432
-81% -$3.92M 0.13% 164
2025
Q2 		$4.23M Sell
10,434
-147
-1% -$61.5K 0.63% 39
2025
Q1 		$5.27M Buy
10,581
+21
+0.2% +$11.4K 0.86% 24
2024
Q4 		$5.49M Sell
10,560
-935
-8% -$514K 0.91% 21
2024
Q3 		$7.11M Buy
11,495
+303
+3% +$179K 1.21% 16
2024
Q2 		$6.19M Sell
11,192
-326
-3% -$187K 1.18% 18
2024
Q1 		$6.69M Buy
11,518
+4,103
+55% +$2.3M 1.24% 13
2023
Q4 		$3.94M Sell
7,415
-537
-7% -$260K 0.73% 34
2023
Q3 		$4.03M Buy
7,952
+317
+4% +$169K 0.76% 35
2023
Q2 		$3.98M Buy
+7,635
New +$4.12M 0.74% 35

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Portside Wealth Group's TMO Position: Q2 2026 in Review

Portside Wealth Group increased its Thermo Fisher Scientific (TMO) stake by 0.4% in Q2 2026, buying an estimated $4.32K and bringing the position to 2,282 shares worth $1.14M. The position accounts for 0.13% of the portfolio, ranked #166.

Portside Wealth Group first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.11M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Portside Wealth Group held 2,282 shares of Thermo Fisher Scientific worth $1.14M as of Q2 2026.
  • Portside Wealth Group bought 9 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.32K.
  • Thermo Fisher Scientific made up 0.13% of Portside Wealth Group's portfolio in Q2 2026, its #166 holding.
  • Portside Wealth Group first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • Portside Wealth Group's Thermo Fisher Scientific position peaked at $7.11M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.